A Global, Randomized, Phase 3, Open-Label Study of REGN2810 (Anti-PD-1 Antibody) versus Platinum-Based Chemotherapy in First-Line Treatment of Patients with Advanced or Metastatic PD-L1 + Non-Small Cell Lung Cancer
Projeler > Desteklenmiş Diğer Projeler · 2018
Yazarlar: Tuncay GÖKSEL
2018-2021, Desteklenmiş Diğer Projeler, AR-GE Projesi, Devam Ediyor